TelePep is direct-pay telehealth with licensed clinician evaluation and, if appropriate, compounded medication dispensed by U.S.-licensed 503A or 503B pharmacies. Pricing also lists tablets, microdose and other wellness programs, which have different clinical and regulatory considerations.
Annual equivalent requires a $2,028 or $2,568 upfront payment. Coverage excludes several states. The company states compounded products are not FDA-approved, not generics and not therapeutically equivalent to branded drugs.
Injectable semaglutide: $199 month-to-month, $567/3 months, $1,074/6 months, or $2,028 annually ($169/month equivalent). Tirzepatide: $249 monthly, $711/3 months, $1,344/6 months, or $2,568 annually ($214/month equivalent). Displayed prices include clinician evaluation, medication and shipping.
Read full review TelePepVisit brand with TelePep (opens in a new tab)Goes to telepeptide.org